Tetsuzo Tagawa

Tetsuzo Tagawa

Auto-generated profile, based on publicly available information

Tetsuzo Tagawa

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2023 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
SWSho Wakasu
Sho Wakasu
TTTetsuzo Tagawa
Tetsuzo Tagawa
NHNaoki Haratake
Naoki Haratake
FKFumihiko Kinoshita
Fumihiko Kinoshita
YOYuka Oku
Yuka Oku
MMMasaki Mori
Masaki Mori

11 July 2020 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
FKFumihiko Kinoshita
Fumihiko Kinoshita
TTTetsuzo Tagawa
Tetsuzo Tagawa
TATakaki Akamine
Takaki Akamine
KTKazuki Takada
Kazuki Takada
YYYuichi Yamada
Yuichi Yamada
MMMasaki Mori
Masaki Mori

26 November 2019 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
FKFumihiko Kinoshita
Fumihiko Kinoshita
KTKazuki Takada
Kazuki Takada
YYYuichi Yamada
Yuichi Yamada
YOYuka Oku
Yuka Oku
KKKeisuke Kosai
Keisuke Kosai
MMMasaki Mori
Masaki Mori

3 March 2021 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
FKFumihiko Kinoshita
Fumihiko Kinoshita
TYTakanori Yamashita
Takanori Yamashita
YOYuka Oku
Yuka Oku
KKKeisuke Kosai
Keisuke Kosai
YOYuki Ono
Yuki Ono
MMMasaki Mori
Masaki Mori
Background/Aim: Albumin-bilirubin (ALBI) grade is an indicator of liver dysfunction and is useful for predicting postoperative prognosis of hepatocellular carcinomas. However, the significance of ALBI grade in non-small cell lung carcinoma (NSCLC) has not been elucidated. Patients and Methods: We analyzed 947 patients with pStage IA-IIIA NSCLC. We divided patients into ALBI grade 1 and grade 2/3 groups. We then analyzed the association of ABLI grade with clinicopathological characteristics and prognosis in NSCLC by using propensity-score matching. Results: ALBI grade 2/3 was significantly associated with older age, male sex, advanced pT status, and histological type. Even after propensity-score matching, ALBI grade 2/3 patients had significantly worse cancer-specific survival (CSS) than ALBI grade 1 patients (5-year CSS: 87.3% versus 92.8%; p=0.0247). In multivariate analysis, ALBI grade 2/3 was an independent predictor of CSS (HR=1.9; 95%CI=1.11-3.11; p=0.0177). Conclusion: ALBI grade was an independent prognostic factor in surgically resected NSCLC.

1 March 2020 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
STShinkichi Takamori
Shinkichi Takamori
TTTetsuzo Tagawa
Tetsuzo Tagawa
GTGouji Toyokawa
Gouji Toyokawa
MSMototsugu Shimokawa
Mototsugu Shimokawa
FKFumihiko Kinoshita
Fumihiko Kinoshita
YMYoshihiko Maehara
Yoshihiko Maehara

28 February 2021 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
HKHirokazu Kitahara
Hirokazu Kitahara
FSFumihiro Shoji
Fumihiro Shoji
TATakaki Akamine
Takaki Akamine
FKFumihiko Kinoshita
Fumihiko Kinoshita
NHNaoki Haratake
Naoki Haratake
MMMasaki Mori
Masaki Mori
The prognostic nutritional index (PNI) is an indicator of systemic immune-nutritional condition and is a well-known prognostic biomarker in lung cancer patients. Tumour-infiltrating lymphocytes (TILs) is a specific histological feature of cancers, influencing an individual’s immunological tumour responses. However, whether PNI can reflect lung cancer patients’ prognosis through local immunity such as TIL is unclear. We selected 64 lung squamous cell carcinoma patients who underwent curative operations. We investigated the significance of preoperative PNI level and evaluated the relationship between PNI and immune cells surrounding the lung cancer tissue using immunohistochemical analysis of a cluster of differentiation (CD)3, CD4, CD8 and CD68. A low-PNI level was significantly associated with a worse postoperative prognosis (P = 0.042). The PNI (hazard ratio 2.768, 95% confidence interval 1.320–5.957; P = 0.007) was an independent prognostic factor. The low-PNI group had a significantly shorter recurrence-free survival and overall survival (P = 0.013 and P = 0.002, log-rank test) compared with the high-PNI group. A significant positive correlation between PNI components including preoperative peripheral blood lymphocyte count and serum albumin concentration, and TILs, was observed. Absolute numbers of TILs in the preoperative high-PNI group were significantly increased compared with those in the preoperative low-PNI group (CD3+ cells; P = 0.002, CD4+ cells; P = 0.049 and CD8+ cells; P = 0.024). The preoperative PNI level was strongly associated with the postoperative outcome in lung cancer patients. Considering the positive relationship between preoperative PNI level and TIL status, preoperative immune-nutritional condition may influence lung cancer patients’ postoperative prognosis through local immunity as well as systemic immune response.